A Stocktwits, News and Mentions. Forecasting Agilent Technologies, Inc. Sentiments







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

A Stock News and Mentions of Agilent Technologies, Inc. Stocktwits

Updated: March 29, 2024 (09:56)

Sector: Healthcare

Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.

We meticulously analyze the sentiment trend in each article for the last 60 days where Agilent Technologies Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Agilent Technologies, Inc. (A).

You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Agilent Technologies stocks.


Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles

News and Mentions of Agilent Technologies, Inc. (A)

March 28, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)

Agilent ( A ) Up 7.6% Since Last Earnings Report: Can It Continue?

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 28, 2024 (12:21) / "Benzinga" (by Avi Kapoor)

Agilent, Shoe Carnival And 2 Other Stocks Insiders Are Selling - Agilent Technologies ( NYSE:A )

The Nasdaq 100 closed higher by around 0.4% on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.
In Article Trend: Neutral
March 28, 2024 (10:15) / "PR Newswire" (by Research and Markets)

World Molecular Diagnostics for Cancer Markets, 2023-2024 and 2027 with Profiles of Over 120 Companies

DUBLIN, March 28, 2024 /PRNewswire/ -- The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.
In Article Trend: Neutral
March 27, 2024 (13:30) / "Benzinga" (by Globe Newswire)

Food Diagnostics Market Size, Share, Growth Drivers, Segmentation, and Leading Players

Chicago, March 27, 2024 ( GLOBE NEWSWIRE ) -- The Food Diagnostics Market refers to the industry involved in the development, production, and distribution of diagnostic tools and technologies used in the food industry.
In Article Trend: Bullish
March 26, 2024 (16:00) / "Benzinga" (by Benzinga Insights)

Inquiry Into Agilent Technologies's Competitor Dynamics In Life Sciences Tools & Services Industry - Agilent Technologies ( NYSE:A )

In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive industry comparison, evaluating Agilent Technologies A in relation to its major competitors in ...
In Article Trend: Somewhat-Bullish
March 20, 2024 (19:45) / "Benzinga" (by Benzinga Insights)

Looking Into Agilent Technologies's Recent Short Interest - Agilent Technologies ( NYSE:A )

Agilent Technologies's A short percent of float has risen 9.82% since its last report. The company recently reported that it has 3.21 million shares sold short, which is 1.23% of all regular shares that are available for trading.
In Article Trend: Somewhat-Bullish
March 18, 2024 (13:30) / "Zacks Commentary" (by Zacks Equity Research)

New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
In Article Trend: Somewhat-Bullish
March 13, 2024 (16:35) / "Benzinga" (by Piero Cingari)

Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs - Agilent Technologies ( NYSE:A ) , Avantor ( NYSE:AVTR )

Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates. Goldman Sachs projects the global obesity market to potentially reach $100 billion by 2030, with a more optimistic outlook suggesting it ...
In Article Trend: Somewhat-Bullish
March 13, 2024 (12:30) / "Benzinga" (by Globe Newswire)

Global In Vitro Toxicology Testing Market Size is projected to reach USD 28.19 billion by 2031, growing at a CAGR of 10.8%: Straits Research

New York, United States, March 13, 2024 ( GLOBE NEWSWIRE ) -- In Vitro toxicology testing is used to determine the toxicity of a substance on non-living cells or tissues. It is a crucial component of preclinical safety evaluation in the pharmaceutical, chemical, and regulatory industries.
In Article Trend: Somewhat-Bullish
March 11, 2024 (09:22) / "Benzinga" (by Globe Newswire)

Al in Omics Studies Market Worth USD 5.44 Billion to 2031 - Exclusive Report by InsightAce Analytic

Jersey City, NJ, March 11, 2024 ( GLOBE NEWSWIRE ) -- InsightAce Analytic Pvt.
In Article Trend: Somewhat-Bullish
March 8, 2024 (22:48) / "PR Newswire"

Protein Expression Market size to grow by USD 2.45 billion from 2023 to 2027, North America accounts for 37% of ... - PR Newswire

Protein Expression Market size to grow by USD 2.45 billion from 2023 to 2027, North America accounts for 37% of ... PR ...
In Article Trend: Somewhat-Bullish
March 8, 2024 (18:30) / "Benzinga" (by Benzinga Insights)

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $11,000 Today - Agilent Technologies ( NYSE:A )

Agilent Technologies A has outperformed the market over the past 15 years by 3.71% on an annualized basis producing an average annual return of 17.29%. Currently, Agilent Technologies has a market capitalization of $43.76 billion.
In Article Trend: Somewhat-Bullish
March 8, 2024 (08:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)

Stocks To Watch: Agilent Technologies Sees Relative Strength Rating Rise To 81

Agilent Technologies ( A ) had its Relative Strength ( RS ) Rating upgraded from 76 to 81 Friday. X This unique rating tracks market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
In Article Trend: Bullish
March 7, 2024 (11:30) / "Benzinga" (by Globe Newswire)

Laboratory Vacuum Pumps Market Anticipated to Surpass USD 3.1 billion by 2031, Projected a CAGR of 5.1% - Report by Transparency Market Research, Inc.

Wilmington, Delaware, United States, March 07, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global laboratory vacuum pumps market is estimated to flourish at a CAGR of 5.1% from 2023 to 2031.
In Article Trend: Somewhat-Bullish
March 7, 2024 (09:43) / "Benzinga" (by Globe Newswire)

Medical Membrane Market Size & Share to Surpass USD 10.2 billion by 2031 | Analysis by Transparency Market Research, Inc.

Wilmington, Delaware, United States, March 07, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global landscape of the medical membrane market promises to flourish with a CAGR of 9.2% by the end of 2031.
In Article Trend: Somewhat-Bullish
March 7, 2024 (07:31) / "Benzinga" (by Globe Newswire)

Biomarkers Market to Reach USD 125.6 billion by 2031, Projected a CAGR of 10.4%: Report Analysis by Transparency Market Research, Inc.

Wilmington, Delaware, United States, March 07, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global biomarkers market is estimated to flourish at a CAGR of 10.4% from 2023 to 2031.
In Article Trend: Somewhat-Bullish
March 6, 2024 (14:30) / "Zacks Commentary" (by Zacks Equity Research)

Why Agilent Technologies ( A ) is a Top Stock for the Long-Term

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
In Article Trend: Somewhat-Bullish
March 6, 2024 (11:20) / "Zacks Commentary" (by Zacks Equity Research)

Should You Invest in the First Trust Water ETF ( FIW ) ?

Sector ETF report for ...
In Article Trend: Somewhat-Bullish
March 5, 2024 (19:21) / "Investors Business Daily" (by Investor's Business Daily)

Agilent Technologies Stock Getting Closer To Key Technical Benchmark

Agilent Technologies ( A ) stock saw a positive improvement to its Relative Strength ( RS ) Rating on Tuesday, rising from 65 to 71. IBD's unique rating tracks market leadership with a 1 ( worst ) to 99 ( best ) score.
In Article Trend: Bullish
March 5, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)

Agilent Technologies Getting Closer To Key Technical Benchmark

Agilent Technologies ( A ) saw a positive improvement to its Relative Strength ( RS ) Rating on Tuesday, rising from 65 to 71. X IBD's unique rating tracks market leadership with a 1 ( worst ) to 99 ( best ) score.
In Article Trend: Bullish
March 1, 2024 (00:36) / "PR Newswire"

Cannabis Testing Market size to grow by USD 1.50 billion from 2022-2027, AB SCIEX LLC, Agilent Technologies Inc ... - PR Newswire

Cannabis Testing Market size to grow by USD 1.50 billion from 2022-2027, AB SCIEX LLC, Agilent Technologies Inc ... PR ...
In Article Trend: Somewhat-Bullish
February 29, 2024 (18:08) / "PR Newswire" (by Elanco Animal Health)

Elanco Animal Health is Executing on Plan to Deliver for Shareholders

Ancora Nominates Director Candidates Despite Elanco's Meaningful Operational Progress and Good Faith Engagement with the Investor
In Article Trend: Somewhat-Bullish
February 29, 2024 (14:00) / "Benzinga" (by Benzinga Insights)

If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today - Agilent Technologies ( NYSE:A )

Agilent Technologies A has outperformed the market over the past 10 years by 2.3% on an annualized basis producing an average annual return of 12.77%. Currently, Agilent Technologies has a market capitalization of $40.28 billion.
In Article Trend: Somewhat-Bullish
February 29, 2024 (12:30) / "Benzinga" (by Globe Newswire)

Transfection Technologies Market is Expected to Reach $1.8 Billion | MarketsandMarkets™

Chicago, Feb. 29, 2024 ( GLOBE NEWSWIRE ) -- Transfection Technologies market in terms of revenue was estimated to be worth $1.2 billion in 2023 and is poised to reach $1.8 billion by 2028, growing at a CAGR of 9.4% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.
In Article Trend: Somewhat-Bullish
February 28, 2024 (14:36) / "Zacks Commentary" (by Zacks Equity Research)

Agilent ( A ) Q1 Earnings & Revenues Beat Estimates, Dip Y/Y

Agilent's (A) first-quarter fiscal 2024 results reflect softness across the LSAG and DGG segments. Weak momentum in China has been concerning.
In Article Trend: Neutral
February 28, 2024 (12:57) / "Associated Press" (by STAN CHOE)

Stock market today: Wall Street drifts as bitcoin bounces again

Stock market today: US markets drift lower before the bell as earnings season draws to a close The Associated Press ...
In Article Trend: Neutral
February 28, 2024 (11:08) / "Benzinga" (by Shanthi Rexaline)

Nasdaq, S&P 500 Futures Decline As Traders Await GDP Data, Fed Speeches; Bitcoin Eyes $60K Milestone: Analysts Highlight Small-Cap Gains As Sign Of Robust Economy - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , SPDR S&P 500 ( ARCA:SPY )

Sentiments turn negative on Wednesday after the mixed performance in the previous session, as the focus shifts to some key Main Street data. Traders may prefer to move to the sidelines to see off some key economic catalysts due for the week.
In Article Trend: Neutral
February 27, 2024 (22:20) / "Zacks Commentary" (by Zacks Equity Research)

Agilent Technologies ( A ) Beats Q1 Earnings and Revenue Estimates

Agilent (A) delivered earnings and revenue surprises of 6.61% and 5.53%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Somewhat-Bullish
February 27, 2024 (10:49) / "Benzinga" (by Shanthi Rexaline)

Nasdaq, S&P 500 Futures Grind Higher After Pause, Bitcoin Tops $56K: Analyst Spotlights 'Big Takeaway' That Augurs Well For Market - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , SPDR S&P 500 ( ARCA:SPY )

U.S. stocks are poised for a potential rebound on Tuesday after facing concerns about valuations in the previous session. Early trading shows modest gains in major index futures, indicating continued market momentum.
In Article Trend: Neutral
February 26, 2024 (20:06) / "Zacks Commentary" (by Shaun Pruitt)

3 Top-Rated Stocks to Consider as Earnings Approach

With representation from a variety of sectors, several top-rated Zacks stocks look attractive ahead of their quarterly reports on Tuesday, February 27.
In Article Trend: Somewhat-Bullish
February 26, 2024 (17:23) / "Zacks Commentary" (by Zacks Equity Research)

Agilent Technologies ( A ) to Post Q1 Earnings: What's in Store?

Agilent's (A) results for the fiscal first quarter are expected to reflect strength across ACG amid weakness in the LSAG and DGG segments.
In Article Trend: Neutral
February 26, 2024 (14:45) / "Zacks Commentary" (by Zacks Equity Research)

Itron ( ITRI ) Q4 Earnings and Revenues Top Estimates

Itron (ITRI) delivered earnings and revenue surprises of 64% and 1.12%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Somewhat-Bullish
February 26, 2024 (14:32) / "Zacks Commentary" (by Zacks Equity Research)

Intuit ( INTU ) Q2 Earnings Beat on Strength in Online Ecosystem

Intuit's (INTU) fiscal second-quarter earnings reflect strong momentum in online ecosystem revenues and solid professional tax revenues.
In Article Trend: Somewhat-Bullish
February 23, 2024 (19:07) / "Zacks Commentary" (by Zacks Investment Research)

NICE Q4 Earnings Top Estimates, Cloud Revenues Drive Top Line

NICE's fourth-quarter 2023 results reflect benefits from robust cloud revenues, driven by increased migration to the cloud and an expanding customer base.
In Article Trend: Somewhat-Bullish
February 23, 2024 (17:23) / "Zacks Commentary" (by Zacks Equity Research)

Block ( SQ ) Q4 Earnings Miss Estimates, Revenues Rise Y/Y

Block's (SQ) fourth-quarter results benefit from the solid momentum across the Square and Cash App ecosystems.
In Article Trend: Neutral
February 23, 2024 (15:39) / "Zacks Commentary" (by Zacks Equity Research)

Intuit ( INTU ) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

Intuit's (INTU) fiscal second-quarter results reflect strength in the Online and Desktop Ecosystem business segments.
In Article Trend: Somewhat-Bullish
February 23, 2024 (15:28) / "Benzinga" (by Globe Newswire)

HPLC Market Anticipated to Surpass USD 6.6 Billion by 2031, Demonstrating 5.3% CAGR | Transparency Market Research, Inc.

Wilmington, Delaware, United States, Feb. 23, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global HPLC market was projected to attain US$ 4.2 billion in 2022. It is anticipated to garner a 5.3% CAGR from 2023 to 2031 and by 2031, the market is likely to attain US$ 6.6 ...
In Article Trend: Somewhat-Bullish
February 22, 2024 (17:12) / "Zacks Commentary" (by Zacks Investment Research)

Photronics ( PLAB ) Q1 Earnings Miss Estimates, Revenues Up Y/Y

Photronics (PLAB) records robust revenue growth in first-quarter fiscal 2024, driven by strong performance in the IC and FPD segments.
In Article Trend: Neutral
February 22, 2024 (15:57) / "Zacks Commentary" (by Zacks Equity Research)

ETSY's Q4 Earnings Meet Estimates, Revenues Increase Y/Y

ETSY's fourth-quarter results reflect strength across active sellers and reactivated buyers, bolstering its services and marketplace revenues.
In Article Trend: Neutral
February 22, 2024 (14:15) / "Zacks Commentary" (by Zacks Equity Research)

Agilent ( A ) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Beyond analysts' top -and-bottom-line estimates for Agilent (A), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended January 2024.
In Article Trend: Neutral
February 22, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)

Charles River Labs Intl Reaches 80-Plus Relative Strength Rating Benchmark

On Thursday, Charles River Labs Intl ( CRL ) reached an important technical milestone, seeing its Relative Strength ( RS ) Rating jump into the 80-plus percentile with an improvement to 83, up from 80 the day before.
In Article Trend: Bullish
February 21, 2024 (17:00) / "Zacks Commentary" (by Zacks Investment Research)

RingCentral ( RNG ) Q4 Earnings Top Estimates, Revenues Up Y/Y

RingCentral's (RNG) Q4 results benefit from strong subscription revenue growth, driven by strong subscription revenues.
In Article Trend: Neutral
February 21, 2024 (16:52) / "Zacks Commentary" (by Zacks Investment Research)

CoStar Group ( CSGP ) Q4 Earnings Beat Estimates, Revenues Up Y/Y

CoStar Group's (CSGP) fourth-quarter 2023 results reflect solid top-line growth, led by robust performance in key segments and acquisitions like OnTheMarket in the U.K.
In Article Trend: Neutral
February 20, 2024 (23:15) / "Zacks Commentary" (by Zacks Equity Research)

Agilent Technologies ( A ) Stock Moves -0.52%: What You Should Know

Agilent Technologies (A) closed at $134.14 in the latest trading session, marking a -0.52% move from the prior day.
In Article Trend: Neutral
February 20, 2024 (12:30) / "Benzinga" (by Globe Newswire)

Microarray Scanners Market Size Estimated to Reach US$ 1.7 billion, Rising at a CAGR of 7.5% by 2031: Transparency Market Research, Inc.

Wilmington, Delaware, United States, Feb. 20, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global microarray scanners market is estimated to flourish at a CAGR of 7.5% from 2023 to 2031.
In Article Trend: Somewhat-Bullish
February 19, 2024 (15:15) / "PR Newswire" (by Research and Markets)

3D Cell Cultures Technologies and Global Markets: Revenue Data for 2020-2022 with Compound Annual Growth Rates ( CAGRs ) Projections Spanning through 2028

3D Cell Cultures Technologies and Global Markets: Revenue Data for 2020-2022 with Compound Annual Growth ... PR ...
In Article Trend: Neutral
February 15, 2024 (12:16) / "Benzinga" (by Globe Newswire)

C-reactive Protein Testing Market Expected to Grow at 2.9% CAGR, Reaching USD 4 billion by 2031: Transparency Market Research, Inc.

Wilmington, Delaware, United States, Feb. 15, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The C-reactive protein testing market was worth US$ 3.1 billion in 2022. A CAGR of 2.9% is projected from 2023 to 2031, and the market will reach more than US$ 4.0 billion in 2031.
In Article Trend: Neutral
February 15, 2024 (12:15) / "Zacks Commentary" (by Zacks Equity Research)

Cognex Corporation ( CGNX ) Matches Q4 Earnings Estimates

Cognex Corporation (CGNX) delivered earnings and revenue surprises of 0% and 4.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Somewhat-Bullish
February 14, 2024 (23:15) / "Zacks Commentary" (by Zacks Equity Research)

Agilent Technologies ( A ) Surpasses Market Returns: Some Facts Worth Knowing

Agilent Technologies (A) reachead $132.24 at the closing of the latest trading day, reflecting a +1.91% change compared to its last close.
In Article Trend: Somewhat-Bullish
February 14, 2024 (13:10) / "Benzinga" (by Globe Newswire)

Polymerase Chain Reaction ( PCR ) Consumables Market Size & Share to Surpass USD 754.4 million by 2031 | Analysis by Transparency Market Research, Inc.

Wilmington, Delaware, United States, Feb. 14, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The polymerase chain reaction ( PCR ) consumables market was valued at US$ 520.5 million in 2022. The market is expected to reach US$ 754.4 million by the end of 2031, expanding at a CAGR ...
In Article Trend: Somewhat-Bullish
February 13, 2024 (17:00) / "Benzinga" (by Benzinga Insights)

$100 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today - Agilent Technologies ( NYSE:A )

Agilent Technologies A has outperformed the market over the past 10 years by 2.33% on an annualized basis producing an average annual return of 12.73%. Currently, Agilent Technologies has a market capitalization of $38.31 billion.
In Article Trend: Somewhat-Bullish
February 13, 2024 (16:30) / "Benzinga" (by Globe Newswire)

Small Cell Lung Cancer Therapeutics Market To Witness Rapid Growth, Surpassing $10 Billion By 2028 As Per The Business Research Company's Small Cell Lung Cancer Therapeutics Global Market Report 2024

LONDON, Feb. 13, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's small cell lung cancer therapeutics global market report 2024, the small cell lung cancer therapeutics market is poised for remarkable growth.
In Article Trend: Neutral
February 12, 2024 (11:30) / "Benzinga" (by Globe Newswire)

Global Rare Disease Diagnostics Market Size is Estimated to Reach USD 71.2 Billion by 2031, Growing at a CAGR of 8.62%: Straits Research

New York, United States, Feb. 12, 2024 ( GLOBE NEWSWIRE ) -- This study examines the effects of uncommon diseases on a significant portion of the global population. There are over 7000 uncommon diseases, and inadequate information is available for many of them, limiting diagnostic and therapeutic ...
In Article Trend: Neutral
February 9, 2024 (12:30) / "Benzinga" (by Globe Newswire)

Molecular Cytogenetics Market is Expected to Reach $4.9 Billion | MarketsandMarkets™

Chicago, Feb. 09, 2024 ( GLOBE NEWSWIRE ) -- Molecular Cytogenetics market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.9 billion by 2028, growing at a CAGR of 9.9% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.
In Article Trend: Neutral
February 8, 2024 (23:15) / "Zacks Commentary" (by Zacks Equity Research)

Agilent Technologies ( A ) Outperforms Broader Market: What You Need to Know

In the most recent trading session, Agilent Technologies (A) closed at $134.07, indicating a +0.96% shift from the previous trading day.
In Article Trend: Somewhat-Bullish
February 7, 2024 (01:15) / "Benzinga" (by Globe Newswire)

Forensic Technologies Market Revenue to Cross USD 87.4 billion by 2028| Transparency Market Research, Inc.

Wilmington, Delaware, United States, Feb. 06, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global forensic technologies market is estimated to flourish at a CAGR of 13.2% from 2021 to 2028.
In Article Trend: Somewhat-Bullish
February 6, 2024 (10:28) / "Benzinga" (by Globe Newswire)

Oligonucleotide Synthesis Market Size to Surpass USD 44.9 Billion By 2033 | Driven by Increasing Demand for Precision Medicine

New York, Feb. 06, 2024 ( GLOBE NEWSWIRE ) -- According to Market.us, the Global Oligonucleotide Synthesis market size is forecasted to exceed USD 44.9 Billion by 2033, with a promising CAGR of 17.3% from 2024 to 2033.
In Article Trend: Somewhat-Bullish
February 6, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)

Myriad Genetics Shows Rising Price Performance With Jump To 88 RS Rating

The Relative Strength ( RS ) Rating for Myriad Genetics ( MYGN ) entered a new percentile Tuesday, with an increase from 79 to 88. When looking for the best stocks to buy and watch, keep a close on eye on relative price strength. IBD's unique rating tracks price movement with a 1 ( worst ) ...
In Article Trend: Bullish
February 6, 2024 (08:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)

Stocks Showing Improved Relative Strength: Charles River Labs Intl

The Relative Strength ( RS ) Rating for Charles River Labs Intl ( CRL ) headed into a new percentile Tuesday, as it got a lift from 68 to 71. X As you try to find the best stocks to buy and watch, keep a close on eye on relative price strength.
In Article Trend: Somewhat-Bullish
February 5, 2024 (17:30) / "Benzinga" (by Globe Newswire)

Gene Synthesis Market Size Set to Reach USD 14.2 billion, at a CAGR of 23.6% by 2033 - Transparency Market Research Inc.

Wilmington, Delaware, United States, Feb. 05, 2024 ( GLOBE NEWSWIRE ) -- The global gene synthesis market is estimated to flourish at a CAGR of 23.6% from 2023 to 2033. Transparency Market Research projects that the overall sales revenue for gene synthesis is estimated to reach US$ 14.2 billion ...
In Article Trend: Somewhat-Bullish
February 5, 2024 (14:24) / "PR Newswire"

3D Optical Microscope Market to grow by USD 113.04 million from 2022 to 2027, Increasing funding for RandD to drive ... - PR Newswire

3D Optical Microscope Market to grow by USD 113.04 million from 2022 to 2027, Increasing funding for RandD to drive ... PR ...
In Article Trend: Neutral
February 5, 2024 (12:51) / "Business Insider" (by George Glover)

US stock futures slip after Fed chair Jerome Powell pours cold water on investors' hopes for early rate cuts

Futures for the Samp;P 500 and Dow Jones Industrial Average were down 0.2% about 7 a.m. ET, while Nasdaq futures slipped 0.1% in early-morning trading. Benchmark 10-year Treasury yields edged up 7 basis points, while a widely followed gauge of the US dollar's strength climbed 0.4%.
In Article Trend: Neutral
February 5, 2024 (12:51) / "Business Insider" (by George Glover)

US stock futures slip after Fed chair Jerome Powell pours cold water on investors' hopes for early rate cuts

Stock Market Today: US Futures Slip After Powell Plays Down Early Rate Cuts - Markets Insider ...
In Article Trend: Neutral
February 2, 2024 (23:15) / "Zacks Commentary" (by Zacks Equity Research)

Agilent Technologies ( A ) Stock Slides as Market Rises: Facts to Know Before You Trade

Agilent Technologies (A) concluded the recent trading session at $132.97, signifying a -0.06% move from its prior day's close.
In Article Trend: Somewhat-Bullish
February 2, 2024 (10:49) / "Benzinga" (by Globe Newswire)

Flow Cytometry Market Anticipated to Reach USD 8.8 billion by 2031, Remarkable CAGR of 8.0% - Analysis Report by Transparency Market Research, Inc.

Wilmington, Delaware, United States, Feb. 02, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The flow cytometry market accounted for US$ 4.4 billion in 2022. A CAGR of 8.0% is expected from 2023 to 2031, resulting in US$ 8.8 billion by 2031.
In Article Trend: Somewhat-Bullish
February 1, 2024 (18:30) / "Benzinga" (by Benzinga Insights)

Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years - Agilent Technologies ( NYSE:A )

Agilent Technologies A has outperformed the market over the past 10 years by 1.62% on an annualized basis producing an average annual return of 12.39%. Currently, Agilent Technologies has a market capitalization of $38.70 billion.
In Article Trend: Somewhat-Bullish
February 1, 2024 (16:40) / "Zacks Commentary" (by Zacks Equity Research)

FTV vs. A: Which Stock Is the Better Value Option?

Investors with an interest in Electronics - Testing Equipment stocks have likely encountered both Fortive ( FTV Quick QuoteFTV - ) and Agilent Technologies ( A Quick QuoteA - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
In Article Trend: Bullish
January 31, 2024 (13:40) / "Zacks Commentary" (by Zacks Equity Research)

Fortive ( FTV ) Q4 Earnings and Revenues Beat Estimates

Fortive (FTV) delivered earnings and revenue surprises of 5.38% and 0.99%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Somewhat-Bullish
January 30, 2024 (11:30) / "PR Newswire" (by Trimble)

Trimble Announces Board Additions and Capital Allocation Update

Kara Sprague and Ron Nersesian elected as new independent directors WESTMINSTER, Colo., Jan. 30, 2024 /PRNewswire/ -- Trimble Inc. ( NASDAQ: TRMB ) announced today the appointment of Kara Sprague and Ron Nersesian to its Board of Directors, effective February 5, 2024.
In Article Trend: Somewhat-Bullish



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.